Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders

SummaryTandem mass spectrometry is currently used in newborn screening programmes to quantify the level of amino acids and acylcarnitines in dried blood spots for detection of metabolites associated with treatable diseases. We have developed assays for lysosomal enzymes in rehydrated dried blood spots in which a set of substrates is added and the set of corresponding enzymatic products are quantified using tandem mass spectrometry with the aid of mass-differentiated internal standards. We have developed a multiplex assay of the set of enzymes that, when deficient, cause the lysosomal storage disorders Fabry, Gaucher, Hurler, Krabbe, Niemann–Pick A/B and Pompe diseases. These diseases were selected because treatments are now available or expected to emerge shortly. The discovery that acarbose is a selective inhibitor of maltase glucoamylase allows the Pompe disease enzyme, acid α-glucosidase, to be selectively assayed in white blood cells and dried blood spots. When tested with dried blood spots from 40 unaffected individuals and 10–12 individuals with the lysosomal storage disorder, the tandem mass spectrometry assay led to the correct identification of the affected individuals with 100% sensitivity. Many of the reagents needed for the new assays are commercially available, and those that are not are being prepared under Good Manufacturing Procedures for approval by the FDA. Our newborn screening assay for Krabbe disease is currently being put in place at the Wadsworth Center in New York State for the analysis of ∼1000 dried blood spots per day. Summary We have developed tandem mass spectrometry for the direct assay of lysosomal enzymes in rehydrated dried blood spots that can be implemented for newborn screening of lysosomal storage disorders. Several enzymes can be analysed by a single method (multiplex analysis) and in a high-throughput manner appropriate for newborn screening laboratories.

[1]  E. Miebach.  Enzyme replacement therapy in mucopolysaccharidosis type I , 2005, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[2]  M. Gelb,et al.  Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for Krabbe disease. , 2004, Clinical chemistry.

[3]  M. Gelb,et al.  Affinity capture and elution/electrospray ionization mass spectrometry assay of phosphomannomutase and phosphomannose isomerase for the multiplex analysis of congenital disorders of glycosylation types Ia and Ib. , 2003, Analytical chemistry.

[4]  B. Wilcken,et al.  Screening newborns for inborn errors of metabolism by tandem mass spectrometry. , 2003, The New England journal of medicine.

[5]  J. Gilbert,et al.  Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22. , 2003, American journal of human genetics.

[6]  P. Meikle,et al.  Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease. , 2001, Clinical chemistry.

[7]  W. Krivit.  Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases , 2004, Springer Seminars in Immunopathology.

[8]  W. C. Hülsmann,et al.  The use of leucocytes as an aid in the diagnosis of glycogen storage disease type II (Pompe's disease). , 1974, Clinica chimica acta; international journal of clinical chemistry.

[9]  R. Cole.  Electrospray ionization mass spectrometry : fundamentals, instrumentation, and applications , 1997 .

[10]  C. Costello,et al.  Tandem mass spectrometry. , 1993, Methods in molecular biology.

[11]  N. Chamoles,et al.  Tay-Sachs and Sandhoff diseases: enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnoses in newborn-screening cards. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[12]  J. Stockman,et al.  Transplantation of Umbilical-Cord Blood in Babies With Infantile Krabbe's Disease , 2007 .

[13]  M. Gelb,et al.  Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening. , 2004, Clinical chemistry.

[14]  P. Meikle,et al.  Determination of oligosaccharides in Pompe disease by electrospray ionization tandem mass spectrometry. , 2002, Clinical chemistry.

[15]  P. Kaplan,et al.  Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). , 2004, The Journal of pediatrics.

[16]  Donald H Chace,et al.  A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing. , 2005, Clinical biochemistry.

[17]  R. Desnick,et al.  Enzyme replacement and enhancement therapies for lysosomal diseases , 2004, Journal of Inherited Metabolic Disease.

[18]  W. Endres,et al.  Diagnosis of Pompe's disease using leukocyte preparations. Kinetic and immunological studies of 1,4-alpha-glucosidase in human fetal and adult tissues and cultured cells. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[19]  M. Gelb,et al.  Design and synthesis of substrate and internal standard conjugates for profiling enzyme activity in the Sanfilippo syndrome by affinity chromatography/electrospray ionization mass spectrometry. , 2001, Bioconjugate chemistry.

[20]  J. DaCosta,et al.  Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[21]  M. Gelb,et al.  Tandem mass spectrometric analysis of dried blood spots for screening of mucopolysaccharidosis I in newborns. , 2005, Clinical Chemistry.

[22]  M. Gelb,et al.  Direct profiling of multiple enzyme activities in human cell lysates by affinity chromatography/electrospray ionization mass spectrometry: application to clinical enzymology. , 2001, Analytical chemistry.

[23]  P. Elliott,et al.  Fabry disease and the heart: an overview of the natural history and the effect of enzyme replacement therapy , 2005, Acta paediatrica (Oslo, Norway : 1992). Supplement.